ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, PROCEPT BioRobotics Corporation (PRCT) shows an Average True Range (ATR) of 2.6 and an Enterprise Value of 2.5B. Its average trading volume over the past 3 months is 918K, indicating liquidity. These fundamental metrics provide insight into PRCT's underlying financial health and market activity.
PROCEPT BioRobotics Corporation (PRCT) technical indicators as of July 20, 2025: the SMA 20 is 0.46%, SMA 50 at -0.08%, and SMA 200 at -16.06%. The RSI 14 value is 50.07, suggesting its current momentum. These technical analysis signals help assess PRCT's price trends and potential future movements.
PROCEPT BioRobotics Corporation (PRCT) stock performance overview as of July 20, 2025: The 52-week high is $103.81 (currently -43.79% below), and the 52-week low is $47.04 (currently 24.04% above). Over the past year, PRCT's performance is -12.7%, compared to the S&P 500's 13.57% change.
According to market data, PROCEPT BioRobotics Corporation (PRCT) stock's recent performance metrics show that over the last month, PRCT is -1.14%, with a Year-to-Date (YTD) performance of -27.53%. Over the past year, the stock has seen a -12.7% change. These figures summarize PRCT's price movements across various periods, reflecting its historical returns.
According to current financial data, PRCT stock's P/E (TTM) ratio is -35.53, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for PRCT, including P/S (12.96), P/B (8.23), and P/FCF (-36.60), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.